Using NESA Microcurrents to Help Children with Autism and Sleep Issues
Utility of NESA Microcurrents in the Treatment of Sleep Disturbances, Disruptive Behaviours of Children With Autism Spectrum Disorders and in the Quality of Life of the Family Unit.
This study is testing whether a new treatment using NESA microcurrents can help children with autism sleep better and improve their behavior.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 2 Years to 18 Years |
| Sex | All |
| Sponsor | University of Las Palmas de Gran Canaria Academic / other |
| Locations | 1 site (Las Palmas de Gran Canaria, Las Palmas) |
| Trial ID | NCT06417450 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of NESA microcurrents in alleviating sleep disturbances in children diagnosed with Autism Spectrum Disorder (ASD). It focuses on how these treatments may influence disruptive behaviors and improve the overall quality of life for both the children and their families. The study will involve non-invasive neuromodulation techniques and will compare the effects of active treatment against a placebo. The project is expected to last for eight months and is being conducted at the University of Las Palmas de Gran Canaria.
Who should consider this trial
Good fit: Ideal candidates include children diagnosed with Autism Spectrum Disorder who experience sleep disturbances and disruptive behaviors.
Not a fit: Patients with contraindications to NESA treatment, such as those with pacemakers or uncontrolled convulsions, may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve sleep quality and reduce disruptive behaviors in children with autism, enhancing their quality of life.
How similar studies have performed: While the approach of using neuromodulation for sleep issues in autism is relatively novel, similar studies have shown promise in addressing behavioral and sleep-related challenges in this population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children with a diagnosis of Autistic Spectrum Disorder, attending school in the City of San Juan de Dios in Las Palmas de Gran Canaria. * Children with symptoms related to sleep disturbances. * Children who present episodes of disruptive behaviour. * Children who may present sensory alterations or cognitive deficits. * Children whose parents sign the informed consent form. Exclusion Criteria: * Present some of the contraindications for treatment with NESA XSIGNAL®: pacemakers, internal haemorrhages, not applying electrodes on skin in poor condition, with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and/or phobia of electricity. * If parents do not sign the informed consent form. * Presence of uncontrolled convulsions.
Where this trial is running
Las Palmas de Gran Canaria, Las Palmas
- University of Las Palmas de Gran Canaria — Las Palmas de Gran Canaria, Las Palmas, Spain (Recruiting)
Study contacts
- Principal investigator: Aníbal Báez Suárez, PhD — University of Las Palmas de Gran Canaria
- Study coordinator: Aníbal Báez Suárez, PhD
- Email: anibal.baez@ulpgc.es
- Phone: +34 928 45 14 11
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.